undefined

Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products

Year of publication

2021

Authors

Ahmed, Muhammad N.; Wahlsten, Matti; Jokela, Jouni; Nees, Matthias; Stenman, Ulf-Håkan; Alvarenga, Danillo O.; Strandin, Tomas; Sivonen, Kaarina; Poso, Antti; Permi, Perttu; Metsä-Ketelä, Mikko; Koistinen, Hannu; Fewer, David P.

Abstract

Serine proteases regulate many physiological processes and play a key role in a variety of cancers. Aeruginosins are a family of natural products produced by cyanobacteria that exhibit pronounced structural diversity and potent serine protease inhibition. Here, we sequenced the complete genome of Nodularia sphaerocarpa UHCC 0038 and identified the 43.7 kb suomilide biosynthetic gene cluster. Bioinformatic analysis demonstrated that suomilide belongs to the aeruginosin family of natural products. We identified 103 complete aeruginosin biosynthetic gene clusters from 12 cyanobacterial genera and showed that they encode an unexpected chemical diversity. Surprisingly, purified suomilide inhibited human trypsin-2 and -3, with IC50 values of 4.7 and 11.5 nM, respectively, while trypsin-1 was inhibited with an IC50 of 104 nM. Molecular dynamics simulations suggested that suomilide has a long residence time when bound to trypsins. This was confirmed experimentally for trypsin-1 and -3 (residence times of 1.5 and 57 min, respectively). Suomilide also inhibited the invasion of aggressive and metastatic PC-3M prostate cancer cells without affecting cell proliferation. The potent inhibition of trypsin-3, together with a long residence time and the ability to inhibit prostate cancer cell invasion, makes suomilide an attractive drug lead for targeting cancers that overexpress trypsin-3. These results substantially broaden the genetic and chemical diversity of the aeruginosin family and suggest that aeruginosins may be a source of selective inhibitors of human serine proteases.
Show more

Organizations and authors

University of Turku

Nees Matthias

Metsä-Ketelä Mikko

University of Helsinki

Poso Antti

Alvarenga Danillo O.

Fewer David P.

Koistinen Hannu

Jokela Jouni

Sivonen Kaarina

Wahlsten Matti

Ahmed Muhammad N.

Permi Perttu

Strandin Tomas

Stenman Ulf Håkan

Helsinki University Hospital

Poso Antti

Alvarenga Danillo O.

Fewer David P.

Koistinen Hannu

Jokela Jouni

Sivonen Kaarina

Wahlsten Matti

Ahmed Muhammad N.

Permi Perttu

Strandin Tomas

Stenman Ulf Håkan

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Parent publication name

ACS Chemical Biology

Volume

16

Issue

11

Pages

2537-2546

​Publication forum

50179

​Publication forum level

2

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Partially open publication channel

Self-archived

Yes

Other information

Fields of science

Chemical sciences; Pharmacy; Biochemistry, cell and molecular biology; Biomedicine; Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United States

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

No

DOI

10.1021/acschembio.1c00611

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes